The authors relate their clinical experience with 46 panic disorder
patients who were receiving 3-10 mg/day of alprazolam. Fifteen (33%)
developed symptoms consistent with DSM-III criteria for major depression
despite remission of their panic symptoms. Clinicians should be alert to
this potentially reversible complication.Abstract Teaser